Clinical Trial Update: 31P MRS Ischaemic Exercise Optimisation and COPD [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from GlaxoSmithKline describes using 31P magnetic resonance spectroscopy during ischemic exercise to optimize outcomes in chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Muscular Atrophy

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atrophy, Muscular | Phase 1 | Status: COMPLETED